GR3036470T3 - Process for preparing a clodronate preparation - Google Patents

Process for preparing a clodronate preparation

Info

Publication number
GR3036470T3
GR3036470T3 GR20010401329T GR20010401329T GR3036470T3 GR 3036470 T3 GR3036470 T3 GR 3036470T3 GR 20010401329 T GR20010401329 T GR 20010401329T GR 20010401329 T GR20010401329 T GR 20010401329T GR 3036470 T3 GR3036470 T3 GR 3036470T3
Authority
GR
Greece
Prior art keywords
clodronate
pct
tetrahydrate
disodium
disodium clodronate
Prior art date
Application number
GR20010401329T
Other languages
Greek (el)
Inventor
Esko Pohjala
Heikki Nupponen
Kari Lehmussaari
Original Assignee
Leiras Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leiras Oy filed Critical Leiras Oy
Publication of GR3036470T3 publication Critical patent/GR3036470T3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
    • A61K31/663—Compounds having two or more phosphorus acid groups or esters thereof, e.g. clodronic acid, pamidronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1688—Processes resulting in pure drug agglomerate optionally containing up to 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Medicinal Preparation (AREA)
  • Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Ceramic Products (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Glass Compositions (AREA)
  • Detergent Compositions (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
  • Peptides Or Proteins (AREA)
  • Seasonings (AREA)
  • Glanulating (AREA)

Abstract

PCT No. PCT/FI94/00509 Sec. 371 Date Aug. 6, 1996 Sec. 102(e) Date Aug. 6, 1996 PCT Filed Nov. 11, 1994 PCT Pub. No. WO95/13054 PCT Pub. Date May 18, 1995The object of the invention is a process for preparing a clodronate preparation. The process is characterized in that clodronate is crystallized as disodium clodronate tetrahydrate from an aqueous solution of disodium clodronate; the resulting disodium clodronate tetrahydrate is dry granulated by compressing in such a way that the crystal structure of the disodium clodronate tetrahydrate is preserved and by crumbling and screening the mass to granules of a sutiable size, the dry granulated disodium clodronate tetrahydrate is optionally mixed with suitable excipients, such as filling agents and gliding agents and, if necessary, disintegrants.
GR20010401329T 1993-11-12 2001-08-30 Process for preparing a clodronate preparation GR3036470T3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FI935019A FI94926C (en) 1993-11-12 1993-11-12 Method for preparing a clodronate preparation
PCT/FI1994/000509 WO1995013054A1 (en) 1993-11-12 1994-11-11 Process for preparing a clodronate preparation

Publications (1)

Publication Number Publication Date
GR3036470T3 true GR3036470T3 (en) 2001-11-30

Family

ID=8538945

Family Applications (1)

Application Number Title Priority Date Filing Date
GR20010401329T GR3036470T3 (en) 1993-11-12 2001-08-30 Process for preparing a clodronate preparation

Country Status (25)

Country Link
US (1) US5776499A (en)
EP (1) EP0727983B1 (en)
JP (1) JPH09504800A (en)
KR (1) KR100352155B1 (en)
CN (1) CN1040945C (en)
AT (1) ATE202700T1 (en)
AU (1) AU679586B2 (en)
CA (1) CA2175994A1 (en)
CZ (1) CZ286132B6 (en)
DE (1) DE69427648T2 (en)
DK (1) DK0727983T3 (en)
ES (1) ES2160688T3 (en)
FI (1) FI94926C (en)
GR (1) GR3036470T3 (en)
HU (1) HU220633B1 (en)
IL (1) IL111596A (en)
NO (1) NO312938B1 (en)
NZ (1) NZ275833A (en)
PL (1) PL176658B1 (en)
PT (1) PT727983E (en)
RU (1) RU2141323C1 (en)
SK (1) SK280552B6 (en)
TW (1) TW436297B (en)
WO (1) WO1995013054A1 (en)
ZA (1) ZA948974B (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI109088B (en) * 1997-09-19 2002-05-31 Leiras Oy Tablet and process for its preparation
DE19808634A1 (en) * 1998-02-24 1999-08-26 Schering Ag Production of pharmaceutical pellets, especially containing iloprost, with stabilized release properties
AR021347A1 (en) 1999-10-20 2002-07-17 Cipla Ltd A PHARMACEUTICAL COMPOSITION CONTAINING SISPHOSPHONIC ACID (S) OR SALT (S) OF THE SAME AND A PREPARATION PROCESS OF THE SAME
RO121891B1 (en) 2001-07-04 2008-07-30 Sindan S.R.L. Pharmaceutical composition for the prophylaxis and treatment of calcium metabolism disorders and process for preparing the same
US7862552B2 (en) 2005-05-09 2011-01-04 Boston Scientific Scimed, Inc. Medical devices for treating urological and uterine conditions
GB0616794D0 (en) 2006-08-24 2006-10-04 Arrow Int Ltd Solid dosage form
CA3009962C (en) * 2015-12-22 2021-11-09 Stock Company "Chepetsky Mechanical Plant" (Sc Cmp) A method of manufacturing rods from titanium alloys
CA3082728A1 (en) 2017-11-22 2019-05-31 Inbiomotion S.L. Therapeutic treatment of breast cancer based on c-maf status
TWI806467B (en) 2022-03-03 2023-06-21 金兆豐數位科技股份有限公司 Multi-dimensional decision-making method for financial products to increase the rate of return

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE60711T1 (en) * 1986-12-20 1991-02-15 Boehringer Mannheim Gmbh PHARMACEUTICALS CONTAINING CLODRONATE AND METHOD OF MANUFACTURE THE SAME.
SE501389C2 (en) * 1992-04-24 1995-01-30 Leiras Oy Pharmaceutical preparation and process for its preparation
AU687744B2 (en) * 1993-05-15 1998-03-05 Riemser Arzneimittel Ag More easily biologically absorbed tablet containing dichloromethylene diphosphonic acid as the active agent

Also Published As

Publication number Publication date
DE69427648D1 (en) 2001-08-09
ZA948974B (en) 1995-11-21
RU2141323C1 (en) 1999-11-20
KR960705548A (en) 1996-11-08
CN1134664A (en) 1996-10-30
HU220633B1 (en) 2002-03-28
ES2160688T3 (en) 2001-11-16
CN1040945C (en) 1998-12-02
EP0727983B1 (en) 2001-07-04
IL111596A0 (en) 1995-01-24
AU679586B2 (en) 1997-07-03
NO312938B1 (en) 2002-07-22
CZ286132B6 (en) 2000-01-12
WO1995013054A1 (en) 1995-05-18
PL314299A1 (en) 1996-09-02
AU8108794A (en) 1995-05-29
KR100352155B1 (en) 2002-12-31
FI94926B (en) 1995-08-15
IL111596A (en) 1998-12-06
HU9601257D0 (en) 1996-07-29
JPH09504800A (en) 1997-05-13
PT727983E (en) 2001-11-30
CA2175994A1 (en) 1995-05-18
NO961906D0 (en) 1996-05-10
DE69427648T2 (en) 2002-04-18
FI94926C (en) 1995-11-27
FI935019A0 (en) 1993-11-12
HUT75228A (en) 1997-04-28
FI935019A (en) 1995-05-13
ATE202700T1 (en) 2001-07-15
DK0727983T3 (en) 2001-09-24
CZ132796A3 (en) 1996-10-16
PL176658B1 (en) 1999-07-30
EP0727983A1 (en) 1996-08-28
SK60696A3 (en) 1997-02-05
TW436297B (en) 2001-05-28
NZ275833A (en) 1997-10-24
US5776499A (en) 1998-07-07
NO961906L (en) 1996-05-23
SK280552B6 (en) 2000-03-13

Similar Documents

Publication Publication Date Title
GR3031936T3 (en) Process for preparing controlled release pharmaceutical forms and the forms thus obtained.
UA37214C2 (en) Water-dispersible tablets and method for their manufacture
GR3035219T3 (en) New active principle-containing microparticles, agents containing the same, their use for the ultrasonically controlled release of active principles, and process for preparing the same
MY104772A (en) Dispersible granules of fungicidal products.
AU1793797A (en) Dosage form of ibuprofen
AU5465186A (en) Devices for the controlled release of active substances, as well as process for the preparation thereof
MY136231A (en) Slow release compositions
MY109990A (en) Microfluidised particles of atovaquone and pharmaceutical preparation thereof
ZA888314B (en) Granular calcium hypochlorite composition and process for preparation thereof
HUT52025A (en) Insecticide compositions containing cyclopropyl-substituted diaryl compounds as active component and process for producing the active components
IL111596A0 (en) Process for preparing a clodronate preparation
MY113718A (en) Pharmaceutical formulation containing a hydrophobic active substance and an effervescent system, and process for the preparation of the formulation
HUT49793A (en) Herbicide compositions containing n-aryl-tetrahydro-phtalimides as active components and process for producing the active components
GR3015719T3 (en) Process for the preparation of a tablet or dragee composition containing a heat-, light- and moisture-sensitive active ingredient having monoclinic crystal structure.
CA2161943A1 (en) Granulated bleaching activators and their preparation
HUT34344A (en) Process for producing tablets controlled dissolution of active ingredients
HUT52069A (en) Herbicide compositions containing sulfonanilide derivatives as active components and process for producing the active components
JPS5767007A (en) Manufacture of granular sodium percarbonate with high solubility
HUT52762A (en) Herbicide compositions containing substituted sulfonyl-urea derivatives as active components and process for producing the active components
EP0247342A3 (en) Comminuting device for making a doughy mass
HUT55604A (en) Fungicide and growth-controlling compositions containing n-oxo-azolyl-methyl-oxiranes as active components and process for producing the active components
HUT48241A (en) Herbicide compositions containing halogenated cyclopropan derivatives as active components and process for producing the active components
JPS53122679A (en) Process for preparing forming tablets
SU1791978A1 (en) Food addition
SU1601940A1 (en) Method of artificial carnallite producing

Legal Events

Date Code Title Description
ML Lapse due to non-payment of fees